CIGNA (CI) Management Meetings Indicate Covid Investment Yield Depends on Continued High Hospitalization Rate - UBS
Tweet Send to a Friend
UBS analyst Kevin Caliendo reiterated a Buy rating and $244.00 price target on CIGNA (NYSE: CI) after hosting virtual meetings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
